Advance Pharmaceutical to invest $25 million in building plant in Russia
18 September 2013
USA-based privately-held drugmaker Advance Pharmaceutical Inc is considering establishing a facility for the production of its drugs in Russia’s Belgorod region (Central Russia), according to the company. Advance Pharmaceutical engages in the design, research and development, manufacture, marketing and distribution of prescription and over the counter pharmaceutical products.
Russia Decides Pre-2013 Device Clinical Trials Can Support Marketing Approval
18 September 2013
Russia’s Federal Service on Healthcare Surveillance (Roszdravnadzor) and the Ministry of Health have agreed that clinical trials conducted on medical devices prior to January 2013 can be used to support applications for the renewal of or new marketing registration for devices in the 2013-2014 timeframe.
In Moscow, microbiologists try to strip germs of defensive power
16 September 2013
In a momentous fundamental science discovery, Russian researchers now appear to know ways of improving antibiotics-based therapies. And not only therapies, as scientists of Moscow’s Vinogradsky Institute of Microbiology said as early as last year. In a broader implication, the research results may also help domestic and global industry prevent corrosion of pipes and equipment.
Russian scientists working on anti-smoking vaccine
10 September 2013
Russian scientists are currently working on the first ever vaccine which could help quit smoking; it may be available in pharmacies in as early as five years. Dmitry Ovchinnikov, Deputy Director General of the company developing the drug, Selecta RUS confirmed: “We’re currently going through the second phase of clinical trials.”
Russian government considers more ways of saving on drug purchases
04 September 2013
China drug probe leads to tougher market, Ipsen CEO says
02 September 2013
Ipsen SA (IPN) Chief Executive Officer Marc de Garidel said it’s becoming more complicated to do business in China as doctors change habits amid a widening local probe of the pharmaceutical industry.
Russian government to change rules on public procurement of drugs
28 August 2013
The Russian government is considering providing permission for the state purchases of essential drugs, in accordance with their brand names, but in line with protection of their chemical formula by patents and the existence of evidences that the drug cannot be replaced by its analogue. Such proposals were recently prepared by the Russian Ministry of Health, Ministry of Industry and Trade and the Federal Antimonopoly Service (FAS).
California Assembly Passes Bill on Biosimilar Drug Use
27 August 2013
Pharmaceutical makers won approval from the California Assembly to restrict generic versions of drugs isolated from natural sources, such as vaccines, known as biosimilars, once they become available in the U.S.
How to invest in Russian technoparks
08 August 2013
Technoparks can be a boon for both foreign investors willing to set up their business in Russia.
Venture capital warms to European biotechs
08 August 2013
While a wave of stock market enthusiasm in the United States for biotech company flotations has yet to cross the Atlantic, venture capital appetite for promising European companies is returning.
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
The Russian government will support the development and production of modern drugs
16 September 2024
Russia’s Long-Lasting Flu Vaccine Undergoes Trials
16 September 2024
Moscow to Launch Digitalization Course for Students
12 September 2024
Russia has created an oral drug aimed at treating obesity and diabetes
12 September 2024